Preclinical assessment of an anti-HTLV-1 heterologous DNA/MVA vaccine protocol expressing a multiepitope HBZ protein.
D S O Daian E SilvaL J CoxA S RochaÁ Lopes-RibeiroJ P C SouzaG M FrancoJ L C PradoThaiza Aline Pereira-SantosMarina Lobato MartinsJordana Grazziela Alves Coelho-Dos-ReisT M Gomes-de-PinhoFlavio Guimarães da FonsecaEdel Figueiredo Barbosa-StancioliPublished in: Virology journal (2023)
Our results highlight the potential of the HBZ multiepitope protein expressed from plasmid DNA and a poxviral vector as candidates for therapeutic vaccine.